Daily Pill Offers Alternative to Weight-Loss Injections Like Ozempic and Wegovy

Speedy Summary

• Progress: A daily pill called orforglipron, developed by US pharmaceutical company Lilly, has shown promise in phase III trials.
• Effectiveness: The pill lowered blood sugar and body weight in people with type 2 diabetes, comparable to injectable drugs such as Ozempic and Wegovy.
• mechanism: Orforglipron is a GLP-1 agonist that mimics a hormone regulating appetite and blood sugar, also aiding treatment of obesity and heart disease.
• Potential Impact: If approved, this medication could offer a needle-free alternative for managing type 2 diabetes and facilitating weight loss.

!campaign=RSS%7CNSNS&utmsource=NSNS&utmmedium=RSS&utm_content=home”>read More